The effects of combination treatments on drug resistance in chronic myeloid leukaemia: an evaluation of the tyrosine kinase inhibitors axitinib and asciminib.

BMC Cancer · 2020 · PMC7204252 · PMID 32380976

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

fairly significantno p-value reported

3 a) where, because of the rapid elimination of dasatinib from the body, there is a fairly significant difference between simultaneous and interleaved administration of the drugs, where the latter is preferable.

also in 581 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.